Document is current

Article History

Accepted: 15 August 2021

First Online: 4 September 2021

Declarations

:

: There was no funding for the study. Dr. Vu’s fellowship was supported by the VA Office of Academic Affiliations.

: Dr. Clancy has been awarded investigator-initiated research grants from Astellas, Merck, Melinta, and Cidara for studies unrelated to this project, served on advisory boards or consulted for Astellas, Merck, the Medicines Company, Cidara, Scynexis, Shionogi, Qpex and Needham & Company, and spoken at symposia sponsored by Merck and T2Biosystems. Dr. Buehrle has served on an advisory board for Shionogi. Dr. Vu conducted this study during her VA fellowship and is now an employee with MedImpact Healthcare Systems, Inc. Dr. Smith and Dr. Aspinall have no conflicts of interest to declare.

: MV and DB conceptualized the study; MV, DJB, SA, and CC were involved in literature search and critical literature review; MV, SA, and KS were involved in analysis and interpretation of data; MV drafted the manuscript; DJB, NC, SA, and KS significantly revised and edited the manuscript; SA and DJB updated the final manuscript; KS completed additional analyses for the final manuscript; NC provided a final review of the manuscript.

: This study was granted exemption from the VA Pittsburgh Institutional Review Board. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Available on request from the authors.

: Not applicable.

: Not applicable.

: Not applicable.